FDA Drug recall D-1523-2022
TEST CYP/DHEA (Sesame Oil) 100 MG/2.5 MG/ML Injection, 3 ML and 6 ML vials, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland,…
- FDA Drug
- Class II
- completed
- Published 2022-09-21
On 2022-09-21 the FDA classified a Class II recall of TEST CYP/DHEA (Sesame Oil) 100 MG/2.5 MG/ML Injection, 3 ML and 6 ML vials, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland,… by Carolina Infusion, citing lack of Assurance of Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1523-2022 |
| Classification | Class II |
| Status | completed |
| Initiated | 2022-08-26 |
| Published | 2022-09-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Carolina Infusion |
| Distribution | US |
Product
TEST CYP/DHEA (Sesame Oil) 100 MG/2.5 MG/ML Injection, 3 ML and 6 ML vials, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
Reason
Lack of Assurance of Sterility
Identifiers
| code_info | Lots: 07182022@9 BUD: 10/16/2022; 07272022@15 BUD: 10/25/2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1523-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.